
TRANEXAMOYL DIPEPTIDE-22
Description
Tranexamoyl Dipeptide-22 is an innovative peptide compound that has gained significant attention in advanced skincare formulations. This synthetic ingredient combines tranexamic acid with a dipeptide, creating a potent molecule designed to address hyperpigmentation and uneven skin tone.
The compound works by inhibiting melanin production through multiple pathways. It interferes with the interaction between keratinocytes and melanocytes, reducing the transfer of melanin to the skin's surface. Additionally, Tranexamoyl Dipeptide-22 helps to stabilize and protect existing collagen, promoting a firmer, more youthful skin appearance.
Clinical studies have shown that Tranexamoyl Dipeptide-22 can effectively reduce the appearance of dark spots and melasma, with visible improvements noted within 4-8 weeks of consistent use. The ingredient is generally well-tolerated and can be used in conjunction with other skin-brightening agents for enhanced results.
Formulations containing Tranexamoyl Dipeptide-22 are typically found in serums, spot treatments, and targeted brightening products. The ingredient is suitable for various skin types and can be particularly beneficial for those struggling with post-inflammatory hyperpigmentation or sun-induced discoloration.